KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Change in Accured Expenses (2016 - 2025)

Humana (HUM) has disclosed Change in Accured Expenses for 16 consecutive years, with $307.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Accured Expenses changed N/A to $307.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 billion, a N/A change, with the full-year FY2024 number at -$373.0 million, down 144.35% from a year prior.
  • Change in Accured Expenses was $307.0 million for Q3 2025 at Humana, down from $817.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $817.0 million in Q2 2025 to a low of -$238.0 million in Q1 2023.
  • A 4-year average of $108.2 million and a median of $53.5 million in 2021 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: surged 870.97% in 2022, then tumbled 131.07% in 2023.
  • Humana's Change in Accured Expenses stood at -$31.0 million in 2021, then soared by 870.97% to $239.0 million in 2022, then tumbled by 199.58% to -$238.0 million in 2023, then soared by 228.99% to $307.0 million in 2025.
  • Per Business Quant, the three most recent readings for HUM's Change in Accured Expenses are $307.0 million (Q3 2025), $817.0 million (Q2 2025), and $193.0 million (Q1 2025).